Paper36914548
Specific activation of cGAS-STING pathway by nanotherapeutics-mediated ferroptosis evoked endogenous signaling for boosting systemic tumor immunotherapy.
Liang JL and 8 others. Sci Bull (Beijing), 2023. Cited by 119 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Specific activation of cGAS-STING pathway by nanotherapeutics-mediated ferroptosis evoked endogenous signaling for boosting systemic tumor immunotherapy. Papers, record 36914548. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36914548
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Specific activation of cGAS-STING pathway by nanotherapeutics-mediated ferroptosis evoked endogenous signaling for boosting systemic tumor immunotherapy.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ferroptosis | Major topic |
| Interferon Type I | Major topic |
| Neoplasms | Major topic |
| Humans | |
| DNA, Mitochondrial | |
| Immunotherapy | |
| Nucleotidyltransferases | |
| STING Protein | |
| Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase |
Source PubMed
Cited by64
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 119 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42966877 | Ultrasound-Activated Ce(IV)-Integrated Biomimetic Nanoplatform for Oxygenation-Reinforced Gas-Sonodynamic Ferroptosis and cGAS-STING-Driven Antitumor Immunity. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42966877 | PubMed |
| 42898967 | The cGAS-STING pathway in ovarian cancer: from genomic instability to immunotherapeutic vulnerability. | Front Immunol | 2026 | https://conductscience.org/library/papers/42898967 | PubMed |
| 42889276 | Metabolic Competition-Driven Antitumor Immunity of glpX-Deficient Engineered Salmonella via Glucose Deprivation and STING Activation in Bladder Cancer. | Cancer Commun (Lond) | 2026 | https://conductscience.org/library/papers/42889276 | PubMed |
| 42789241 | Pharmacological targeting of ferroptosis in cancer: mechanisms, tumor immunity, and translational challenges. | Pharmacol Rep | 2026 | https://conductscience.org/library/papers/42789241 | PubMed |
| 42675490 | Resetting the immune setpoint of cold tumors through a ferroptosis-cGAS-STING amplification circuit. | J Transl Med | 2026 | https://conductscience.org/library/papers/42675490 | PubMed |
| 42409781 | The emerging Nexus of STING signaling and ferroptosis: from mechanisms to therapeutic opportunities. | Cell Death Discov | 2026 | https://conductscience.org/library/papers/42409781 | PubMed |
| 42404632 | Cantharidin-manganese based cocktail nanoplatform Co-activating ferroptosis and STING for enhanced HCC immunotherapy. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42404632 | PubMed |
| 42293383 | Dual-functional catalytic photothermal immunological agent for ferroptosis induction and cGAS-STING pathway activation: Enhancing tumor immunotherapy and generating robust immune memory. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42293383 | PubMed |
| 42220425 | Liquid-Liquid Phase Separation in Cancer Drug Resistance: Mechanisms and Therapeutic Opportunities. | Oncol Res | 2026 | https://conductscience.org/library/papers/42220425 | PubMed |
| 42094765 | Bibliometric analysis of genetically engineered bacteria in tumor therapy. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42094765 | PubMed |
| 42039278 | Engineered apoptotic vesicle mimetics with tunable "eat-me" signaling precisely regulate tumor-associated macrophages for potentiating cancer immunotherapy. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42039278 | PubMed |
| 41957797 | Ferroptosis as a therapeutic target in cancer: mechanisms, immune interactions, and emerging strategies. | Mol Cancer | 2026 | https://conductscience.org/library/papers/41957797 | PubMed |
| 41940332 | TRIM36 and CAMK2N2 regulate ferroptosis and antigen presentation in small cell lung cancer. | iScience | 2026 | https://conductscience.org/library/papers/41940332 | PubMed |
| 41909233 | Degradable STING nanomodulators orchestrate the innate-to-adaptive immune response for NIR-II photothermal-immunotherapy via a cancer-immunity cycle. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41909233 | PubMed |
| 41881950 | The cGAS-STING pathway in cancer: friend or foe. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/41881950 | PubMed |
| 41864909 | A degradable multi-metal-chelating stealth nanoplatform for dual ferroptosis/cuproptosis-enhanced metalloimmunotherapy in leukemia. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/41864909 | PubMed |
| 41852884 | Biomimetic nanoplatform with multienzyme cascade activity boosting ROS generation and immune activation feedback for tumor therapy. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41852884 | PubMed |
| 41840368 | Platinum-free triplet therapy with nab-paclitaxel, S-1, and tislelizumab as first-line treatment for advanced gastric/gastroesophageal junction adenocarcinoma: a phase ii single-arm trial. | BMC Cancer | 2026 | https://conductscience.org/library/papers/41840368 | PubMed |
| 41704299 | Ultrasound-triggered carrier-free nanoprodrugs activate cGAS-STING pathway to enhance tumor-targeting chemo-immunotherapy. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41704299 | PubMed |
| 41624530 | Copper-enriched zinc peroxides induced cuproptosis through concurrent metabolic and oxidative dysregulation for boosting immunotherapy in colorectal cancer. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41624530 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CGAS | 115004 | PubTator's text mining | https://conductscience.org/library/genes/115004 | NCBI Gene |
| STING1 | 340061 | PubTator's text mining | https://conductscience.org/library/genes/340061 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36914548
GET https://conductscience.org/api/papers/v1/36914548/cited_by?page=2